News Search Results
Mar 21, 2024, 10:42 ET OcuMension (01477.HK) Invests Over RMB 123.8 Million in Research, Technology and Self-development Progress in Tandem, Main Product Sales Show Comprehensive Growth
and efficient medical services. Chasing light and encountering, forging ahead. The development of innovative drugs in the field of Chinese ophthalmology is arduous but promising. With the continuous improvement in market recognition of the company's products, OcuMension will continue to uphold the
More news about: OcuMension
Mar 21, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update
urologic diseases for over 50 years. HanAll has also expanded its focus to immunology, oncology, neurology, and ophthalmology to discover and develop innovative medicines for patients with diseases for which there are no effective treatments. Its lead pipeline asset, HL161
More news about: HanAll Biopharma
Mar 20, 2024, 22:30 ET 百萬里程譜新篇 | ICL晶體植入量全球突破300萬
2016;123:1036-1042 © 2016 by the American Academy of Ophthalmology） 1 EVO ICL accounts for approximately 2.5 million of the 3 million total ICLs sold.2 Ophthalmology 2016;123:1036-1042 © 2016 by the American Academy of Ophthalmology. 關於STAAR Surgical 40多年來，STAAR
More news about: STAAR Surgical
Mar 20, 2024, 07:41 ET Innovent Announces 2023 Annual Results and Business Updates
company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces its 2023 annual results and major business updates. Dr. Michael Yu,
More news about: Innovent Biologics
Mar 19, 2024, 17:20 ET Dental Cone Beam Computed Tomography Market size is to grow by USD 322.95 million from 2022 to 2027, Rising oral health awareness will drive growth, Technavio
ophthalmology devices market size is estimated to grow by USD 19.93 billion at a CAGR of 4.65% between 2022 and 2027.
More news about: Technavio
Mar 19, 2024, 10:01 ET Optometry Equipment Market Worth $6.1 billion | MarketsandMarkets™
prevalence of ocular diseases, the rapidly aging population, the accessibility of state-of-the-art optometry equipment, and the growing utilization of ophthalmology procedures and therapies in this field. Request Sample Pages:
More news about: MarketsandMarkets
Mar 19, 2024, 08:00 ET Covenant High Plains Surgery Center reaccredited as West Texas' only ambulatory surgery Center of Excellence for bariatric weight loss surgery
well as advanced surgical treatment options in bariatrics, ENT, general surgery, GI, gynecology, interventional pain, neuro & spine surgery, ophthalmology, orthopedics, maxillofacial, plastic & reconstructive surgery, podiatry, and urology to patients from Texas,
More news about: Covenant High Plains Surgery Center
Mar 18, 2024, 20:00 ET 信達生物宣佈IBI302（抗VEGF/補體）治療新生血管性年齡相關性黃斑變性（nAMD）的第二項II期臨床研究達成主要終點
factor. Clinical Ophthalmology (Auckland, N.Z.). 2010;4:275-283.[4] Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, SEVEN-UP Study Group. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology. 2013;120(11):2292-2299.
More news about: 信達生物
Mar 18, 2024, 20:00 ET Innovent Announces Primary Endpoint Met in the Second Phase 2 Clinical Trial of IBI302 (anti-VEGF/complement) in Treating Neovascular Age-related Macular Degeneration (nAMD)
future. Professor Xiaodong Sun, Principal Investigator of the Study, Head of National Center for Clinical Ophthalmology, Shanghai General Hospital, stated: "Intravitreal injection of anti-VEGF drugs is currently the first-line treatment for nAMD, but there are
More news about: Innovent Biologics
Mar 18, 2024, 11:18 ET Near Infrared Imaging Market Projected to Reach $3.60 billion by 2030 - Exclusive Report by 360iResearch
coherence tomography (NIR-OCT) offers non-invasive, micrometer-resolution, three-dimensional imagery instrumental in diagnosing retinal diseases in ophthalmology and assessing vascular pathologies in cardiology. Additionally, NIR spectrometers have revolutionized various sectors by providing rapid, non-destructive
More news about: 360iResearch
Mar 18, 2024, 05:36 ET Gene therapy market size to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 39% to the growth, Technavio
US, Canada, UK, China, and Japan Technavio has segmented the market based on therapy areas (oncology, CNS, ophthalmology, rare diseases, and others), and delivery mode (in vivo and ex vivo). The market growth in the oncology segment will be
More news about: Technavio
Mar 13, 2024, 14:00 ET Global Intraocular Lens Market Forecast to 2029, by Type (Monofocal, Premium, Phakic), Material (Hydrophobic, Hydrophilic, Silicone) and Application (Cataract, Presbyopia, Corneal Disorder)
into Hospitals, Ophthalmology Clinics, Eye Research Institutes, and Others. Ophthalmology clinics is accounted for the second largest segment. A growing number of patients are looking for improved IOL options that are personalised to their requirements and preferences. Ophthalmology clinics frequently
More news about: Research and Markets
Mar 12, 2024, 08:00 ET Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD
"Longbio Pharma"), a leading biotech company dedicated to developing innovative protein treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases, proudly announced the Phase I data of LP-003 (new generation of anti-IgE antibody) at the 2024 American
More news about: Longbio Pharma
Mar 12, 2024, 07:45 ET Capsida Biotherapeutics Announces Promotion of Rob Murphy to Chief Manufacturing and Quality Officer
programs, the company has validating CNS partnerships with AbbVie, Lilly, CRISPR Therapeutics, and the AbbVie partnership was expanded to include ophthalmology disorders. Capsida was founded in 2019 by lead investors Versant Ventures and Westlake Village BioPartners and originated from groundbreaking research
More news about: Capsida Biotherapeutics
Mar 12, 2024, 07:00 ET Clario and Cleveland Clinic's Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials
trials, today announced a strategic partnership with the Cleveland Clinic's renowned Cole Eye Institute. The partnership brings Cleveland Clinic's ophthalmology imaging expertise and AI-driven analysis platforms together with Clario's industry-leading vendor-agnostic image management system. The collaboration
More news about: Clario
Mar 12, 2024, 07:00 ET Clario and Cleveland Clinic's Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials
trials, today announced a strategic partnership with the Cleveland Clinic's renowned Cole Eye Institute. The partnership brings Cleveland Clinic's ophthalmology imaging expertise and AI-driven analysis platforms together with Clario's industry-leading vendor-agnostic image management system. The collaboration
More news about: Clario
Mar 11, 2024, 22:47 ET TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation
Australia emerges as a strategic focal point for establishing operations in all our business units, including Ophthalmology, Dermatology, Neurology, Oncology, and Strategic Resourcing. Australia's expanding market aligns perfectly with
More news about: TFS
Mar 11, 2024, 22:45 ET TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation
Australia emerges as a strategic focal point for establishing operations in all our business units, including Ophthalmology, Dermatology, Neurology, Oncology, and Strategic Resourcing. Australia's expanding market aligns perfectly with
More news about: TFS
Mar 11, 2024, 21:09 ET Deputy Defense Minister of Ukraine, Nataliia Kalmykova, will be speaking at the LA Convention Center this week
neurology, spine and cerebrovascular diseases, multiple sclerosis, regenerative medicine, stem cell research, neuro-oncology, Alzheimer's disease, ophthalmology, neurotrauma and military medicine, optometry and neurotech innovations.
More news about: Society for Brain Mapping and Therapeutics
Mar 11, 2024, 20:00 ET Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates (ADCs) from
More news about: Innovent Biologics
Mar 11, 2024, 06:52 ET Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients
segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Its Specialty Generics
More news about: Mallinckrodt plc
Mar 07, 2024, 10:30 ET Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Meshes], Orthobiologics, Fracture Fixation [Bone Plates, Screws, Pins, Rods, Wires]), Ophthalmology (Contact Lenses, Intraocular Lenses, Functional Replacement of Ocular Tissues, Synthetic Corneas, Other Ophthalmology Products), Dental (Dental Implants, Dental Bone Grafts & Substitutes, Dental Membranes,
More news about: MarketsandMarkets
Mar 07, 2024, 10:15 ET Smart Packaging Innovation Pushes Ophthalmic Market to $527.8 Million by 2034
pharmaceutical packaging industry, and specific segments such as plastic packaging solutions. Furthermore, it delves into the interconnected world of ophthalmology drugs to provide a holistic understanding of market dynamics.
More news about: Future Market Insights
Mar 07, 2024, 08:30 ET BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
years at Roche and Genentech, she served in a number of senior roles across therapeutic areas, including immunology, infectious disease, oncology, ophthalmology and hemophilia. She brings significant expertise and leadership experience in both launching and growing successful new medicines. "I am
More news about: BioMarin Pharmaceutical Inc.
Mar 06, 2024, 22:41 ET Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024
Diseases, Chinese Ophthalmology Branch, Chinese Medical Association; Group of Thyroid Diseases, Chinese Endocrinology Branch, Chinese Medical Association. Chinese Guidelines for the Diagnosis and Treatment of Thyroid Associated Ophthalmopathy (2022). Chinese Journal of Ophthalmology. 2022; 58 (9).
More news about: Innovent Biologics